FDA Investigator Robert S Sweeton

Robert S Sweeton has conducted inspections on 195 sites in 3 countries as of 18 Jul 2011. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
195
Last Inspection Date:
18 Jul 2011
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Germany, Turkey
FDA Investigators that have inspected at least one site in common with Robert S Sweeton:
Abby Lmozeke Baker, Ademola O Daramola, Aleta T Flores, Alexander M Kay, Allen F Hall, Amy A Johnson, Ana Djurdjevic, Ana S Cabrera, Anderson, Angela Shepas, Angelina M Albert, April P Shaw, Armando Chavez, MS, Arsen Karapetyan, Beverly A Thomas, Brentley S Collins, Brian P Putz, Bruce W Benware, Bryce A May, Carol F Robinson, Cathleen A Carr Sharpe, Celeta S Coves, Charles D Boison, Charles L Larson, Comyar Shoghi, Courtney N Long, Creighton T Tuzon, Daniel W Cline, Darla J Christopher, Darrin E Davis, Davis, Dejon N Harris, Dennis M Farley, Dennis R Hudson, Diana L Ayala, Diana M Rand, Diane Cvan Leeuwen, Donna Ltartaglino Besone, Doretha M Tonkins, Doretha M Wilson, Douglas J Scott, Dylan R Jock, Emily S Mcgann, Emmanuel B Diric, Eric Zhu, Frank J Marciniak, Gabriel M Guevarra, Gail L Katz, Garrad R Poole, Gene D Arcy, Geoffrey M Leist, Gerald Mierle, Heika R Tait, Herminio C Francisco, Humberto Z Gomez, James D Hildreth, James P Stallings, Jeffrey D Sloan, Jinnie Kokiatkulkij, Jocelyn E Massey, John A Daubenspeck, John A Iwen, Judy C Nepsa, Julian C Hanson, Ka L Wong, Karen J Bak, Kathleen B Swat, Kazuhiro Okumura, Kelley L Clark, Kellie L Thommes, RN, Kelvin Cheung, Kenneth S Boehnen, Kevin T Gerrity, Kristin M Abaonza, Laura A Munsterman, Lauren E Swantko, Laurie A Haxel, Laurissa S Flowers, Laverne Kimble, Lawrence H Howell, Lee Terry Moore, Leo J Lagrotte, Leonard H Lavi, Linda S Mattingly, Linda Thai, Maira P Brading, Marcus F Yambot, Mark C Saale, Mary Ewilkerson Brinsko, Mary T Carden, Mei Chen Mu, Melissa D Kalik, Melsomar R Ramos, Michael D Garcia, Michael N Roberts, Michael S Araneta, Minh D Phan, Mizanne E Lewis, Natalie J Ayoub, Paul M Chefor, Paul M Kawamoto, Phillip L Toy, Raymond W Brullo, Rochelle A Rolnik, Roger D Gawne, Sara Jdent Acosta, Scott K Zika, Selene T Torres, Shaquenta Y Perkins, Shelley H Beausoleil, Sheri L Stephenson, Sherri N Rohlf, MD, Sonya L Karsik, RAC, Sparky L Bartee, Steven E Porter, Jr, Sunitha K Rajaram, PhD, Tania Y Hall, Tawny L Colling, Terrance L Thomas, Terri L Jones, Thanh B Tran, Thomas R Beilke, Timothy P Lafave, Tonia L Sawyer, Travis R Hunt, Travis S Bradley, Trudy R Papson, Vanessa R Muller, Vickie L Anderson, Vien Q Le, Virgilio F Pacio, CSO, Yvette E Guillermo, Yvette Mlacour Davis, Yvonne C Wilkes

Robert S Sweeton's Documents

Publish Date Document Type Title
December, 2003 EIR UCSD - Lifesharing - EIR, 2003-12-03
November, 2001 EIR Yu, Alice, L. - EIR, 2001-11-16
August, 2000 EIR San Diego Blood Bank - EIR, 2000-08-04
August, 2005 FDA 483 Onelegacy-redland - Form 483, 2005-08-04
February, 2002 FDA 483 Biomat USA Inc - Form 483, 2002-02-01
November, 2001 FDA 483 Yu, Alice, L. - Form 483, 2001-11-16
February, 2002 EIR Biomat USA Inc - EIR, 2002-02-01
December, 2003 FDA 483 Response UCSD - Lifesharing - Form 483R, 2003-12-30
December, 2003 FDA 483 UCSD - Lifesharing - Form 483, 2003-12-03

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more